Family-owned Danish firm Orifarm has announced a significant investment from Carlyle Global Credit, which the company says will help it to pursue expansion plans that include both organic and inorganic growth.
Founded in 1994, Orifarm covers three business areas – Pharma Trade, Specialty Rx and Consumer Healthcare – and bills itself as “Europe’s largest parallel importer of pharmaceuticals and Denmark’s largest supplier of pharmaceuticals,” with
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?